Local Evaluation and Blinded Central Review Comparison: A Victim of Meta-Analysis Shortcomings

David Raunig; Gregory Goldmacher; James Conklin

doi:10.1177/2168479013499572

Enriched recordOpen access

Local Evaluation and Blinded Central Review Comparison: A Victim of Meta-Analysis Shortcomings

David Raunig, Gregory Goldmacher, James Conklin

Therapeutic Innovation & Regulatory Science2013doi:10.1177/2168479013499572

Citation graph

Read manuscript

Open PDF in a new tab

If your browser cannot display the PDF here, use “Open PDF in a new tab”.

Abstract

No public abstract is available from the verified source records.

Open public full text

Rights: ALLOWED · cc-by · Source: journal-auto-sync:CROSSREF_ISSN

Read manuscript

Open PDF in a new tab

If your browser cannot display the PDF here, use “Open PDF in a new tab”.

Authors

David Raunig#1 Gregory Goldmacher#2 James Conklin#3

Institutions

No ROR-resolved institution is linked to this work yet.

Provenance

crossref

Confidence 100%

pubmed

Confidence 98%

europepmc

Confidence 96%

unpaywall

Confidence 95%

datacite

Confidence 0%

Referenced works

View all references →

Evaluation of Blinded Independent Central Review of Tumor Progression in Oncology Clinical Trials: A Meta-analysis

2013 · 0 citations

Cited by

View all cited-by records →

No local citing links have been materialized yet.

Read manuscript

Open PDF in a new tab

If your browser cannot display the PDF here, use “Open PDF in a new tab”.

External reference records

10.1177/0092861512459733

10.1177/0092861512459733 · 2013

10.1016/j.ejca.2011.02.013

10.1016/j.ejca.2011.02.013 · 2011

10.1200/jco.2010.28.0982

10.1200/jco.2010.28.0982 · 2011

Unresolved referenced work

Kept as external metadata until matched

Additional external references

No additional external references are available.